Targeted drugs in focus ahead of canc...

Targeted drugs in focus ahead of cancer meeting

There are 2 comments on the WNWN-FM Battle Creek story from May 19, 2011, titled Targeted drugs in focus ahead of cancer meeting. In it, WNWN-FM Battle Creek reports that:

The next wave of cancer therapy is focused on better ways of matching medicines to patients and on keeping tumors from recurring following successful treatment.

Join the discussion below, or Read more at WNWN-FM Battle Creek.

Since: Dec 05

Reading, PA

#1 May 20, 2011
Just think of all the time and money that could be saved if the drugs we already have were used more wisely, instead of concocting all these new and horrendously expensive targeted drugs and relying on maintenance therapy?

Many conventional chemotherapy drugs, in addition to killing tumor cells, also fight angiogenesis. The anti-angiogenic effects of therapy are masked and marginalized by the way it is usually administered. There are generally long breaks between drug administration that are necessary to allow the patient to recover from the harmful side effects of treatment.

When administering these drugs, the endothelial cells (involved in angiogenesis) are the first in the tumor to undergo cell death (apoptosis). However, this anti-angiogenic effect does not translate into a significant therapeutic benefit because the damage to the vasculature of the tumor can be largely repaired during the long rest and recovery periods between successive cycles of therapy.

The more frequent, lower-dose therapy can have an impressive anti-angiogenic and anti-tumor effects. Blood vessel cells are less likely than tumor cells to become resistant to chemotherapy, so if cancer cells become drug resistant, these medicines should still be able to shrink tumors by destroying their blood supply.

The main targets of dose-dense chemotherapy are proliferating tumor cells. The main targets of low-dose chemotherapy are the endothelial cells of the growing vasculature of a tumor. In other words, chemotherapeutics can be used as anti-angiogenic agents.

But this type of protocol willl never make the pharmaceutical companies gobs of money!
#3 Sep 23, 2013
I have ordered 2 times from this website PILLSMEDSHOP. COM . I called yesterday the customer care and asked for a discount as i was about to order twice the regular amount.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Oncology Discussions

Title Updated Last By Comments
News Genomic fingerprint may predict aggressive pros... Jul 21 Spotted Girl 1
News Depression common after serious illness or medi... Jul 13 Jaimie 3
News New Drug Shows Potential for Blood Cancer Jun '15 Johnwillton 2
News $20M cancer center opens today in Clifton Park Jun '15 Dennis S 1
News Researchers hail new cancer treatment that unlo... Jun '15 Hypothetical 1
News CTCA Oncologist Discusses Cancer Risks Among Mi... May '15 Ms Louisiana 1
News Risk of a calamity if North haze not tackled ur... Apr '15 norman 1
More from around the web